⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
Latest News
NYSE to Commence Delisting Proceedings Against Elme Communities (ELME)
businesswire.com
ELME
Salesforce Grants Equity Awards to m3ter and Fin Under Its Inducement Equity Incentive Plan
businesswire.com
CRM
ArriVent to Present Initial Phase 1 Data for CDH17-targeted ADC ARR-217 in Patients with Gastrointestinal Cancers at the ESMO Congress 2026
globenewswire.com
AVBP
Rockford Fosgate Returns as the Official Audio Partner for NFI Empire's Project REBORN, Continuing Its Commitment to The Brett Boyer Foundation
accessnewswire.com
PATK
FOX NEWS MEDIA TO PRESENT LIVE MULTIPLATFORM COVERAGE SURROUNDING THE 2026 MIDTERM ELECTIONS
prnewswire.com
FOXA
ROKU Investors Have Opportunity to Join Roku, Inc. Fraud Investigation with SBS Law
businesswire.com
ROKU
CZR Investors Have Opportunity to Join Caesars Entertainment, Inc. Fraud Investigation with SBS Law
businesswire.com
CZR
DEPH Labs Appoints Lisa Loud as CEO to Accelerate Privacy-Centric Precision Health and Biological Age Testing
globenewswire.com
AAPL
PYPL
Warhound Launches with $200 Million to Rebuild America's Military Working Dog Supply, Using Advanced Genetics and Defense Technology
prnewswire.com
NDLS
SCHW
PLTR
U.S. FDA Approves Subcutaneous Induction Regimen for AbbVie's SKYRIZI® (risankizumab-rzaa) for Adults With Moderately to Severely Active Crohn's Disease
prnewswire.com
ABBV